Physician profile
Anthony Strickland
NPI 1790048239
$1,968.42
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $120 · 2021: $810 · 2022: $835.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $364.75 | 2021-2022 | |
| Glaxosmithkline, LLC. | $181.06 | 2019-2022 | |
| Lilly USA, LLC | $145.82 | 2020-2022 | |
| Amgen INC. | $125.40 | 2020-2022 | |
| Pfizer INC. | $115.82 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $102.78 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.07 | 2021-2022 | |
| Novo Nordisk INC | $73.33 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $66.73 | 2022 | |
| Antares Pharma, INC. | $65.79 | 2021 | |
| Mylan Specialty L.P. | $62.58 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $52.06 | 2019 | |
| Eisai INC. | $51.98 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $51.56 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $45.46 | 2020-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $44.14 | 2021-2022 | |
| Abbott Laboratories | $43.77 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $39.26 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $35.06 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.91 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $25.75 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $23.35 | 2021 | |
| Astellas Pharma US INC | $20.32 | 2021 | |
| Biofire Diagnostics, LLC | $17.30 | 2021 | |
| Biomerieux INC | $17.30 | 2021 | |
| Nevro Corp. | $15.64 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.96 | 2022 | |
| Endo Pharmaceuticals INC. | $14.69 | 2021 | |
| Neurelis, INC. | $14.59 | 2022 | |
| Alexion Pharmaceuticals, INC. | $12.68 | 2020 | |
| Esperion Therapeutics, INC. | $12.51 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Strickland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.